macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.MPP diagnostic criteria: A diagnosis can be made based on medical history, clinical symptoms, signs, and imaging findings, as well as meeting one of the following positive laboratory diagnostic criteria: (1) MP antibody titer increases by four times or more during the recovery phase compared to the acute phase; (2) MP culture positive or MP-DNA or RNA positive. 2.Macrolide-unresponsive M. pneumoniae pulmonary (MUMPP) was defined when children with MPP exhibit persistent fever and no improvement or worsening in clinical signs and pulmonary imaging after 72 hours of standard macrolide treatment. 3.The child himself/herself or his/her guardian signs the informed consent to participate in this study;
Exclusion criteria
Exclusion criteria: 1.patients with primary or secondary immune deficiency/dysfunction, congenital heart disease, chronic liver or kidney disease, oncologic disorders, connective tissue disease, chronic lung disease; 2.patients with evidence of mixed infection; 3.patients with incomplete medical records;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adverse drug reaction;Proportion of refractory Mycoplasma pneumoniae pneumonia; | — |
Secondary
| Measure | Time frame |
|---|---|
| days of fever;Improvement in chest imaging;days of hospitalisation;Improvement of inflammatory indicators; | — |
Countries
China
Contacts
Children's Hospital,Zhejiang University School of Medicine